The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Our Food & Beverage and FDA teams explore a plan from a trio of federal agencies that seeks to implement regulatory reform and update the Coordinated Framework for the Regulation of Biotechnology. The ...

Like other commissions set up by Congress—such as the Cyberspace Solarium Commission that provided crucial cybersecurity measures—the National Security Commission on Emerging Biotechnology (NSCEB) was ...

Experts discuss biotechnology's role in advancing personalized medicine at a VIT webinar, highlighting career opportunities ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...

A senior professor from Jamia Millia Islamia University told ThePrint that the tenure of most of the university’s ...

Even during this tense election year, bipartisan coalitions are taking steps to enhance national security, protect American-owned intellectual property and secure the country’s supply chain by ...

Safeguarding national security increasingly depends on two powerful technological domains: Information Technology and Biotechnology. Both fields are reshaping how governments detect threats, prevent ...